Korsana Biosciences completes merger with Cyclerion Therapeutics, to trade as KRSA on NasdaqPUBT·Sep 11, 2026 at 08:26 PMCYCN0.00%KRSA+1.22%
Niche Markets See Deal Flow: Enhabit’s USD 1.1B Buyout and Precigen’s Revenue SurgeGlobal Report·Sep 9, 2026 at 10:11 AMQUIK+1.31%ATCH-1.46%
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga_article·Sep 4, 2026 at 12:05 PMBTAI0.00%CYCN0.00%
Cyclerion Therapeutics held shareholder meeting, quorum metPUBT·Aug 27, 2026 at 10:10 AMCYCN0.00%KRSA+1.22%
Cyclerion sets Sept. 4 record date for CVR distribution tied to Korsana mergerPUBT·Aug 26, 2026 at 11:12 AMCYCN0.00%KRSA+1.22%
Wall Street's Leftover Chips: Who's Pivoting and Who's Pretending?Global Report·Aug 25, 2026 at 10:12 AMCYCN0.00%WST+0.75%
Cyclerion FY26 Q2 net loss widens to $1.76 million; revenue falls to no revenuePUBT·Aug 4, 2026 at 09:18 PMCYCN0.00%KRSA+1.22%
14:55 ETAre OGN, TBRG, CYCN Obtaining Fair Deals for their Shareholders?prnewswire·May 4, 2026 at 06:55 PMOGN+0.44%TBRG0.00%
15:30 ETAre UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Shareholders?prnewswire·Apr 9, 2026 at 07:30 PMNSA0.00%ULYX0.00%
14:15 ET$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--CYCN, CECO, THR, and CWANprnewswire·Apr 8, 2026 at 06:15 PMCYCN0.00%CWAN0.00%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Apr 6, 2026 at 12:05 PMANVS+3.42%CYCN0.00%
Pre-market hot trades in US stocks: Oriental Rise pre-market down 15.77%; Cyclerion Therapeutics pre-market down 10.24%Price Alert·Apr 6, 2026 at 08:47 AMORIS0.00%CYCN0.00%
Immunovant eye drug flunks Phase 3 studies; Beam sickle cell data published in NEJMbiopharmadive·Apr 3, 2026 at 03:40 PMPBE+2.80%OCEA0.00%
